Should children with inherited metabolic disorders receive varicella vaccination?

M Varghese1, M Cafferkey, M O'Regan

  • 1National Centre for Inherited Metabolic Disorders, Children's University Hospital, Dublin, Ireland.

Insights

Children with disorders of intermediary metabolism (IEM) face increased risks of severe varicella (chickenpox) complications. Varicella vaccination may be beneficial for this vulnerable pediatric population.

Area of Science:

  • Pediatric Infectious Diseases
  • Metabolic Disorders
  • Immunization

Background:

  • Disorders of intermediary metabolism (IEM) represent a group of rare genetic conditions affecting metabolic pathways.
  • Varicella (chickenpox) is a common childhood viral illness, typically mild but can cause severe complications in immunocompromised or chronically ill individuals.

Purpose of the Study:

  • To determine the incidence and severity of varicella infections and associated complications in children diagnosed with IEMs.
  • To evaluate the potential benefit of varicella vaccination in this specific pediatric cohort.

Main Methods:

  • Retrospective review of medical records for children aged 1-16 years attending a national metabolic referral center.
  • Data collection included history of varicella infection, vaccination status, and occurrence of complications.

Main Results:

  • Out of 122 children with IEMs, 64 (53%) had a history of varicella infection, and 5 (4%) were vaccinated.
  • Five children with a history of varicella infection required hospitalization for complications, including lactic acidosis and metabolic decompensation.
  • Forty-three percent of patients lacked a clear history of clinical varicella infection.

Conclusions:

  • Varicella infection poses a significant risk of precipitating metabolic decompensation in children with IEMs.
  • Consideration of varicella vaccination for children with IEMs is recommended, with careful monitoring of safety and efficacy.

Related Concept Videos

Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Vaccinations01:51

Vaccinations

Overview
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...